RAY ANDERSON

Lobbying for 340B HEALTH · Association of 1,400 hospitals operating within the 340 B precription drug policy

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$21,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
Health Resources & Services Administration (HRSA)
HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Pharmacy

340B regulatory policy regarding contract pharmacy 340B regulatory policy regarding a proposed rebate payment model

Health Issues

Contract Pharmacy (no bill), Advocating against pharmaceutical manufacturers' efforts to limit 340B covered entities to one contract pharmacy per 40-mile radius Rebate Model (no bill) Advocating against pharmaceutical manufacturers' efforts to switch the 340B program to a rebate model from a discount structure.

Medicare/Medicaid

Advocating against the adverse impact on Medicaid and Medicare patients by the efforts of pharmaceutical manufacturers to impose restrictions on contract pharmacies

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.